← Russell 3000 cross-section

MMSI MERIT MEDICAL SYSTEMS INC

Trailing twelve months to 2026-06-30 · as filed 2026-07-30, not restated
Healthcare

Scale

Market cap
$5.4bn
Revenue TTM
$1.6bn
Net income TTM
$146m
Free cash flow
$203m
Composite score
51.9
Sector rank
#1041

Valuation

P / E
36.8
EV / EBITDA
17.3
EV / sales
3.6
FCF yield
3.79%
Earnings yield vs 10-yr
-2.01pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
9.2%
EBITDA margin
20.6%
ROE
8.7%
ROIC
10.2%
Revenue growth
10.2%

Insider activity, last 90 days

Net open-market
$-2.50m
Buyers
0
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

For the three-month period ended June 30, 2026, we reported sales of $418.8 million, an increase of $36.4 million or 10% compared to sales for the three-month period ended June 30, 2025 of $382.5 million. For the six-month period ended June 30, 2026, we reported sales of $800.7 million, an increase of $62.9 million or 9% compared to sales for the six-month period ended June 30, 2025 of $737.8 million. Foreign currency fluctuations (net of hedging) increased our net sales by $3.0 million and $10.9 million for the three and six-month periods ended June 30, 2026, respectively, assuming applicable foreign exchange rates in effect during the comparable prior-year periods. …MERIT MEDICAL SYSTEMS INC, 10-Q, period ended 2026-06-30, filed 2026-07-30

Read the full passage →